This country profile provides an overview of Ghana’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
73%
Blinding trachoma
N/A
Intestinal worms
37%
Bilharzia
91%
River blindness
86%
8.81 million
people received treatment in Ghana in 2019
8.41 million
people did not receive treatment in Ghana in 2019
Elephantiasis
Treatment coverage increased from 72% in 2018 to 73% in 2019.
People needing treatment
1.35m
People receiving treatment
979k
Trachoma
Ghana has eliminated blinding trachoma as a public health problem.
Intestinal worms
Treatment coverage increased from 12% in 2018 to 37% in 2019.
Pre-sch and school-aged children needing treatment
10.90m
Pre-school and school-aged children receiving treatment
4m
Bilharzia
Treatment coverage increased from 24% in 2018 to 91% in 2019.
School-aged children needing treatment
4.37m
School-aged children receiving treatment
3.97m
River blindness
Treatment coverage increased from 67% in 2018 to 86% in 2019.
People needing treatment
7.62m
People receiving treatment
6.53
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Ghana.